Comprehensive one-step molecular analyses of mitochondrial genome by massively parallel sequencing

Clinical Chemistry

Volumn 58, Issue 9, 2012, Pages 1322-1331

  Zhang, Wei ^a,b   Cui, Hong ^a   Wong, Lee Jun C ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NAB 2015 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

AMPLICON; ANALYTICAL ERROR; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA ISOLATION; GENE AMPLIFICATION; GENE DELETION; GENE SEQUENCE; HETEROPLASMY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MASSIVELY PARALLEL SEQUENCING; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL GENOME; MOLECULAR DIAGNOSIS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BASE SEQUENCE; DNA PRIMERS; DNA, MITOCHONDRIAL; HUMANS; POINT MUTATION; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS;

EID: 84865778511     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.181438     Document Type: Article

References (37)

1. Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008;83:254-60.
2. Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, Cohen BH. Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 2007;120:1326 -33.
3. Wong LJ. Molecular genetics of mitochondrial disorders. Dev Disabil Res Rev 2010;16:154-62.
4. Wong LJ, Scaglia F, Graham BH, Craigen WJ. Current molecular diagnostic algorithm for mitochondrial disorders. Mol Genet Metab 2010;100: 111-7.
5. Tan DJ, Bai RK, Wong LJ. Comprehensive scanning of somatic mitochondrial dna mutations in breast cancer. Cancer Res 2002;62:972- 6.
6. Tan DJ, Chang J, Chen WL, Agress LJ, Yeh KT, Wang B, Wong LJ. Novel heteroplasmic frameshift and missense somatic mitochondrial DNA mutations in oral cancer of betel quid chewers. Genes Chromosomes Cancer 2003;37:186 -94.
7. Arnold RS, Sun CQ, Richards JC, Grigoriev G, Coleman IM, Nelson PS, et al. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. Prostate 2009;69: 1-11.
8. Dasgupta S, Hoque MO, Upadhyay S, Sidransky D. Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Res 2008;68:700-6.
9. Procaccio V, Neckelmann N, Paquis-Flucklinger V, Bannwarth S, Jimenez R, Davila A, et al. Detection of low levels of the mitochondrial tRNALeu (UUR) 3243A>G mutation in blood derived from patients with diabetes. Mol Diagn Ther 2006;10:381-9.
10. Wallace DC. Mitochondrial DNA mutations in disease and aging. Environ Mol Mutagen 2010;51: 440-50.
11. Rohlin A, Wernersson J, Engwall Y, Wiklund L, Björk J, Nordling M. Parallel sequencing used in detection of mosaic mutations: comparison with four diagnostic DNA screening techniques. Hum Mutat 2009;30:1012-20.
12. Shanske S, Wong LJ. Molecular analysis for mitochondrial DNA disorders. Mitochondrion 2004; 4:403-15.
13. Chinault AC, Shaw CA, Brundage EK, Tang LY, Wong LJ. Application of dual-genome oligonucleotidearray-based comparative genomic hybridization to the molecular diagnosis of mitochondrial DNA deletion and depletion syndromes. Genet Med 2009;11:518 -26.
14. Wong LJ, Dimmock D, Geraghty MT, Quan R, Lichter-Konecki U, Wang J, et al. Utility of oligonucleotide array-based comparative genomic hybridization for detection of target gene deletions. Clin Chem 2008;54:1141- 8.
15. Wong LJ, Senadheera D. Direct detection of multiple point mutations in mitochondrial DNA. Clin Chem 1997;43:1857- 61.
16. Wang J, Venegas V, Li F, Wong LJ. Analysis of mitochondrial DNA point mutation heteroplasmy by ARMS quantitative PCR. Curr Protoc Hum Genet 2011;Chapter 19:Unit 19.6.
17. Brautbar A, Wang J, Abdenur JE, Chang RC, Thomas JA, Grebe TA, et al. The mitochondrial 13513G>A mutation is associated with Leigh disease phenotypes independent of complex I deficiency in muscle. Mol Genet Metab 2008;94: 485-90.
18. Wang J, Brautbar A, Chan AK, Dzwiniel T, Li FY, Waters PJ, et al. Two mtDNA mutations 14487T>C (M63V, ND6) and 12297T>C (tRNA Leu) in a Leigh syndrome family. Mol Genet Metab 2009;96:59-65.
19. Ware SM, El-Hassan N, Kahler SG, Zhang Q, Ma YW, Miller E, et al. Infantile cardiomyopathy caused by a mutation in the overlapping region of mitochondrial ATPase 6 and 8 genes. J Med Genet 2009;46:308 -14.
20. Bai RK, Wong LJ. Detection and quantification of heteroplasmic mutant mitochondrial DNA by realtime amplification refractory mutation system quantitative PCR analysis: a single-step approach. Clin Chem 2004;50:996 -1001.
21. Sadikovic B, Wang J, El-Hattab A, Landsverk M, Douglas G, Brundage EK, et al. Sequence homology at the breakpoint and clinical phenotype of mitochondrial DNA deletion syndromes. PLoS ONE 2010;5:e15687.
22. Anderson DJ. Determination of the lower limit of detection. Clin Chem 1989;35:2152-3.
23. Gilder JR, Doom TE, Inman K, Krane DE. Runspecific limits of detection and quantitation for STR-based DNA testing. J Forensic Sci 2007;52: 97-101.
24. Ruiz-Pesini E, Lott MT, Procaccio V, Poole JC, Brandon MC, Mishmar D, et al. An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res 2006;35:D823- 8.
25. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009;461:272- 6.
26. Roach JC, Glusman G, Smit AFA, Huff CD, Hubley R, Shannon PT, et al. Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 2010;328:636 -9.
27. Tang S, Huang T. Characterization of mitochondrial DNA heteroplasmy using a parallel sequencing system. Biotechniques 2010;48:287-96.
28. Li M, Schönberg A, Schaefer M, Schroeder R, Nasidze I, Stoneking M. Detecting heteroplasmy from high-throughput sequencing of complete human mitochondrial DNA genomes. Am J Hum Genet 2010;87:237- 49.
29. He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE, et al. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 2010;464:610-4.
30. Holland MM, McQuillan MR, O'Hanlon KA. Second generation sequencing allows for mtDNA mixture deconvolution and high resolution detection of heteroplasmy. Croat Med J 2011;52:299- 313.
31. Nakamura K, Oshima T, Morimoto T, Ikeda S, Yoshikawa H, Shiwa Y, et al. Sequence-specific error profile of Illumina sequencers. Nucleic Acids Res 2011;39:e90.
32. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000;287:2017-9.
33. Polyak K, Li Y, Zhu H, Lengauer C, Willson JKV, Markowitz SD, et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 1998;20:291-3.
34. Wong LJ, Lueth M, Li XN, Lau CC, Vogel H. Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res 2003;63:3866 -71.
35. Kurtz A, Lueth M, Kluwe L, Zhang T, Foster R, Mautner VF, et al. Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors. Mol Cancer Res 2004;2:433- 41.
36. Habano W, Sugai T, Yoshida T, Nakamura S. Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int J Cancer 1999;83:625-9.
37. Wong LJ, Tan DJ, Bai RK, Yeh KT, Chang J. Molecular alterations in mitochondrial DNA of hepatocellular carcinomas: is there a correlation with clinicopathological profile? J Med Genet 2004;41:e65.